Cognitive Regulation Training and Exercise (CORTEX)

December 8, 2014 updated by: University of Illinois at Urbana-Champaign

Cognitive Regulation Training and Exercise (CORTEX) Trial

The purpose of this study is to compare CORTEX (Cognitive Regulation Training and Exercise), a multi-faceted, general and exercise-specific cognitive training program plus a 4-month exercise program, to an attention-control condition involving health and wellness informational lectures plus videos. The proposed exercise program will involve both aerobic and resistive exercises. The investigators hypothesize that pre-intervention cognitive training will enhance self-regulation and self-efficacy and in turn, increase exercise adherence. The investigators also expect more positive improvements in cognitive and psychosocial function among participants in the CORTEX condition as compared to the Control condition immediately following the cognitive booster training, and across time.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Primary Aim 1: To determine the efficacy of pre-intervention cognitive training for improving exercise adherence and engagement. We hypothesize that class participation rates, physical activity counts, and self-reported exercise participation levels will be higher at 4 months for participants in the CORTEX condition relative to the Control condition. We also predict that pre-intervention training will demonstrate high feasibility/acceptability, as indicated by a thorough process evaluation.

Primary Aim 2: To determine if integrated general and exercise-specific cognitive training improves facets of executive function and exercise-related efficacy judgments. We hypothesize that participants in the CORTEX condition will show faster reaction times and greater accuracy for trained and untrained-domain-relevant tasks, including dual task performance, reasoning, and thought-stopping at post-booster testing and 4-month follow-up. Furthermore, we hypothesize that CORTEX participants will show significantly higher levels of exercise efficacy judgments, and exhibit greater automaticity (faster reaction times) in making those judgments, at post-booster testing, 1 month and 4-month follow-up.

Secondary Aim 1: We will use longitudinal mediation analyses to examine mechanisms of change brought about by the cognitive training effects on exercise adherence and engagement. We hypothesize that changes in efficacy and use of self-regulatory strategies will mediate cognitive training effects on exercise adherence over 4-months.

Study Type

Interventional

Enrollment (Actual)

133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Urbana, Illinois, United States, 61801
        • University of Illinois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • men and women
  • between 45-64 years old at time of study
  • physically inactive for the past 3 months
  • have reliable access to internet
  • do NOT own or play exergames (Xbox Kinect, Playstation Move, or Nintendo Wii) regularly
  • do NOT engage in "brain-training" regularly
  • are NOT enrolled in another exercise program or cognitive training study
  • willing to be randomized
  • able to participant in the full length of the 5-month study with no more than 2 consecutive weeks of vacation

Exclusion Criteria:

  • <45 or >64 years of age at time of study
  • physically active (i.e., planned 30-min walking or exercise >2 days/wk)
  • do not have reliable access to internet
  • own and/or play exergames regularly (e.g., 1 day/wk)
  • engage in "brain-training" regularly (e.g., Sudoku or computer game-play 1 day/wk)
  • enrolled in another exercise program or cognitive training study
  • cognitive impairment as defined by TICS score <21
  • depression as defined by Geriatric Depression Scale score >5

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CORTEX
The CORTEX group will attend 10, 2-hour sessions for a period of four weeks prior to the initial exercise program start. One hour will be devoted to computerized training (stationary dual-task & cognitive control training, self-priming, certainty training) whereas the other hour will be devoted to exergaming involving non-stationary, dual-task training.
2-hour sessions for a period of four weeks prior to the initial exercise program start. One hour will be devoted to computerized training (stationary dual-task & cognitive control training, self-priming, certainty training) whereas the other hour will be devoted to exergaming involving non-stationary, dual-task training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
exercise adherence
Time Frame: 4 months (from exercise intervention baseline to 4-month post-test)
  • number of weekly classes attended (out of 16 total)
  • frequency of electronically-recorded visits to the fitness facility
4 months (from exercise intervention baseline to 4-month post-test)
exercise program engagement
Time Frame: 4 month period (exercise intervention start to end)
  • self-reported physical activity
  • activity counts assessed via accelerometer
  • weekly exercise logs
  • website usage & percentage of online educational modules completed
4 month period (exercise intervention start to end)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
automaticity of exercise-related efficacy judgments
Time Frame: 5-month period
-reaction times and interference associated with a novel self-efficacy judgment task; collected at baseline, m1, and m5
5-month period
exercise-related self-efficacy
Time Frame: 5-month period
-self-reported confidence in one's ability to adhere to different aspects of the exercise program; collected at baseline, m1, m2, and m5
5-month period
executive functioning
Time Frame: 5-month period
-trained and untrained domains of executive functioning (e.g., dual-task ability, inhibitory control, reasoning) and memory assessed via computer-based and pencil-paper tasks; collected at baseline, 1m, and 5m
5-month period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sean P Mullen, Ph.D., University of Illinois at Urbana-Champaign

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

April 17, 2013

First Submitted That Met QC Criteria

April 19, 2013

First Posted (Estimate)

April 22, 2013

Study Record Updates

Last Update Posted (Estimate)

December 10, 2014

Last Update Submitted That Met QC Criteria

December 8, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 1R21HL11341001A1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Compliance

Clinical Trials on CORTEX

Subscribe